TheEdgeResearch
Home / Stocks / LITH

BioELife Corp. (LITH)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$941
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.50
52-Wk Range
0.000001-0.0002
CEO
Michael Terpin
Country
US
Currency
USD

BioELife Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Seal Beach, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $941. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 1.50 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-3.75
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.86
Current ratio
0.27
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2009-08-07
Headquarters
Seal Beach, CA, US
About BioELife Corp.

BioELife Corp. operates in cannabinoid market. It offers cannabinoid products, such as combo adult gummies with chirorub, combo tincture with chirorub, intensive relief rub, tinctures, adult gummies, premium pre-rolls, and flowers. The company was formerly known as US Lithium Corp. and changed its name to BioELife Corp. in March 2020. The company was founded in 2006 and is based in Seal Beach, California.

Comparable companies

BioELife Corp. is most often compared with the following Healthcare names:

AMHDCFRXQDMKPQEFTRIMVIFMILCMMTCOMMHPJETUTRS
More research on LITH
LITH technical analysis LITH TheEdge Score Compare against peers
Open full interactive analysis & DCF →